Literature DB >> 19391324

Post operative nausea and vomiting in adult Nigerians.

J O Olatosi1, O T Kushimo, C I Okeke, O O Oriyomi.   

Abstract

BACKGROUND: This is a prospective study to determine the pattern of postoperative nausea and vomiting in a Nigerian adult population.
METHOD: 348 consecutive patients were assessed prospectively for the incidence and risk factors of postoperative nausea and vomiting over a 6-month period. The exclusion criteria included inability to give consent, nausea or vomiting during the period 24 hours before surgery, raised intracranial pressure and patients who received an anti-emetic in the period 48 hours before surgery. RESULT: Patient's age ranged between 18 and 90 years. There were 213 females (61.2%) and 135 males (38.8%). The incidence of postoperative nausea was 32.2% and vomiting was 20.1%. The major risk factors identified were female gender, body mass index, general anaesthesia-inhalational technique, Ketamine induction, pancuronium, pain and movement of patients from the recovery room to surgical wards (p < 0.05).
CONCLUSION: Nausea and vomiting was identified as a common postoperative complication with multifactoral aetiology. It is recommended that high risk patients should receive prophylactic antiemetics. Regional techniques should also be considered in such patients.

Entities:  

Mesh:

Year:  2008        PMID: 19391324

Source DB:  PubMed          Journal:  Nig Q J Hosp Med        ISSN: 0189-2657


  2 in total

1.  Postoperative nausea and vomiting in a gynecological and obstetrical population in South Eastern Nigeria.

Authors:  Okafor Ugochukwu; Amucheazi Adaobi; Richard Ewah; Okezie Obioma
Journal:  Pan Afr Med J       Date:  2010-10-19

2.  Symptom trajectories during chemotherapy in patients with non-small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy.

Authors:  Jinghao Liu; Xingyu Liu; Ming Dong; Honglin Zhao; Mei Li; Hongbing Zhang; Huihui Ji; Yi Shi; Yajie Cui; Di Wu; Gang Chen; Jun Chen
Journal:  Thorac Cancer       Date:  2021-01-25       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.